Artiva Biotherapeutics (ARTV) Payables (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Payables of $2.3 million for Q1 2026, up 12.28% year-over-year from $2.0 million in Q1 2025, and up 543.94% quarter-over-quarter from $355000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Payables (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Payables for 4 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 12.28% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 12.28% YoY), while the FY2025 annual figure was $355000.0, down 68.33% from the prior year.
- Payables grew to $2.3 million in Q1 2026 per ARTV's latest filing, from $355000.0 in the prior quarter.
- Across five years, Payables topped out at $2.3 million in Q1 2026 and bottomed at $355000.0 in Q4 2025.
- Historically, Payables has averaged $1.2 million across 4 years, with a median of $1.1 million in 2024.
- Annual changes were most pronounced in 2024 — Payables jumped 82.57% — and 2025, when it tumbled 68.33%.
- Artiva Biotherapeutics' Payables stood at $614000.0 in 2023, then jumped by 82.57% to $1.1 million in 2024, then sank by 68.33% to $355000.0 in 2025, then surged by 543.94% to $2.3 million in 2026.
- Business Quant data shows ARTV's Payables at $2.3 million in Q1 2026, $355000.0 in Q4 2025, and $848000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.39 Mn |
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 355,000.00 |
| Sep 30, 2025 | 848,000.00 |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 823,000.00 |
| Dec 31, 2023 | 614,000.00 |